Research news

Progress towards Apple Watch based tracking of symptoms

Date

Save Parkinson’s clinical research. Take part today

Date

Celebrating neuroscience in spring 2023

Date

Vitamin B3 supplement shows early promise for Parkinson's

Date

Researchers in Norway have published results from an early stage clinical study looking at the potential of a dietary supplement for people with Parkinson's.

The NADPARK study, a phase 1 clinical trial in newly diagnosed people with Parkinson's, showed promising signs that vitamin B3 supplements may have protective effects on the brain.
A person holding a handful of berries

Positive effect of a flavonoid-rich diet seen in people with Parkinson's

Date

Researchers, including scientists from Queen's University Belfast, have discovered that people with Parkinson's who eat more flavonoids may have a longer life expectancy.

Exercise improves symptoms by changing the way the brain works

Date

Researchers in the Netherlands discover that regular exercise may improve Parkinson’s symptoms by creating connections between areas of the brain affected by the condition.

Working together to drive forward race equality in research

Date

We’ve teamed up with leading patient engagement organisations COUCH Health and Egality Health to make Parkinson’s research more accessible, relevant and inclusive.

Take part in groundbreaking research to test drugs to combat coronavirus

Date

If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.

 
Research pipette

Parkinson's protein test could lead to earlier and better diagnosis

Date

Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages. 

We're investing up to £3m in drugs that could slow the progression of Parkinson’s

Date

We’re investing in research into inflammation that could help develop drugs that slow the progression of Parkinson’s, something no current medication can do.

Clinical trial of new dyskinesia drug starts in Sweden

Date

The first participant has been recruited to a pioneering clinical trial which is testing a new drug called NLX-112 to investigate its potential for people with Parkinson’s.

Working together to put patients at the heart of Parkinson's research

Date

UCB, a global pharmaceutical company, has joined forces with Parkinson's UK, and the Parkinson's Foundation in the US, to establish a Patient Engagement Council for Parkinson's Research.

Launch of a new toolkit for researchers

Date

We’ve developed an interactive communications toolkit to help researchers in all areas of health research to keep in touch with their participants. It is supported by the Health Research Authority (HRA) as part of the Make It Public strategy.